Home » News » AIM News » Transense Technologies plc Significant iTrack Order for installation in mines in North America
Transense Technologies plc

Transense Technologies plc Significant iTrack Order for installation in mines in North America

Transense Technologies plc (LON: TRT), the provider of sensor systems for the industrial, mining and transportation markets, has today announced that a customer has placed an order for 50 iTrack II units for installation in mines in North America.

Graham Storey, CEO of Transense Technologies plc, commented:

“We are delighted with this new relationship. The Customer is a major supplier to the mining marketplace and their decision to adopt iTrack II after extensive testing is a very gratifying endorsement of the capabilities of Translogik and the iTrack II system. While there is no actual further commitment in place, we anticipate that sales to the Customer will reach very substantial levels by the end of our next financial year. We look forward to working closely with them both providing iTrack II to their customers and also developing further enhancements and improvements in the future.”

The iTrack II Mining system provides fast, accurate, reliable real-time data on the condition of the tyres, combined with live tracking of vehicle location and status. Our 24/7 Control Room monitors the pressures and temperatures live, and this information can, for example, be used to ensure tyres do not exceed critical heat thresholds, detect incorrect load distributions, predict suspension failures, eliminate manual tyre pressure checks and much more. All of these benefits increase health and safety as well as reducing maintenance and downtime, which maximises the hours a truck is working (On-Road Truck Working Hours), which directly correlates to an increase in production.

Existing iTrack users have reported increases in tyre life of up to 30% and fuel savings of up to 3%. Savings of this magnitude provide a rapid return on investment with the iTrack system paying for itself on a subscription basis from day one.

Follow this article (for updates)
X

Follow this article (for updates)

E-mail : *
* Your personal data will be used to support your experience throughout this website and for other purposes described in our Privacy Policy. I hereby agree and consent to the privacy policy.